ACETYLCHOLINE RECEPTOR BINDING ANTIBODY (ACHR), SERUM Test in UAE

Acetylcholine Receptor Binding Antibody (AChR), Serum Test in Dubai and across the UAE to help diagnose myasthenia gravis (MG), a chronic autoimmune neuromuscular disorder. This blood test detects antibodies that attack acetylcholine receptors at the neuromuscular junction, disrupting nerve-to-muscle communication. Highly specific and essential for confirming autoimmune MG, results are available within 5–7 days.

Overview

The Acetylcholine Receptor (AChR) Binding Antibody test measures the presence and level of autoantibodies in the blood that target acetylcholine receptors on muscle cells. These antibodies block or destroy receptors, impairing muscle contraction and leading to progressive weakness — hallmark signs of myasthenia gravis (MG). This test is the most specific blood test for diagnosing generalized MG, with over 80% positivity in adults with the condition. Results are typically available within 5–7 business days.

Why You Need This Test

• Confirm a suspected diagnosis of myasthenia gravis in patients with fluctuating muscle weakness.
• Evaluate unexplained drooping eyelids (ptosis), double vision (diplopia), or facial weakness.
• Assess difficulty swallowing, slurred speech, or limb weakness that worsens with activity.
• Differentiate MG from other neurological conditions like Lambert-Eaton syndrome, ALS, or multiple sclerosis.
• Support diagnosis in patients with thymoma (thymus tumor), which is strongly linked to AChR antibodies.
• Guide treatment decisions involving immunosuppressive therapy or thymectomy.
• Available with home blood collection service across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms of Myasthenia Gravis

• Drooping eyelids (ptosis) — often one-sided or variable
• Double or blurred vision (diplopia)
• Difficulty swallowing (dysphagia) or choking on liquids
• Slurred speech (dysarthria) that worsens with talking
• Weakness in arms, hands, legs, or neck muscles
• Facial muscle weakness causing expressionless appearance
• Breathing difficulties in severe cases (myasthenic crisis)
• Symptoms typically worsen with activity and improve with rest

Risk Factors

• Women under 40 and men over 60 are most commonly affected
• Autoimmune disorders (e.g., lupus, rheumatoid arthritis, thyroid disease)
• Thymus abnormalities — including thymic hyperplasia or thymoma
• Family history of autoimmune diseases
• Recent infections or immune triggers may precede symptom onset
• Medications like penicillamine or checkpoint inhibitors (rarely)

How the Test Works

In myasthenia gravis, the immune system mistakenly produces antibodies against acetylcholine receptors at the neuromuscular junction — the site where nerves signal muscles to contract. The AChR binding antibody test uses radioimmunoprecipitation to detect these antibodies in serum. When present, they confirm an autoimmune basis for muscle weakness.

• Step 1 — Appointment: schedule a simple blood draw at home or at a certified lab.
• Step 2 — Sample collection: a trained phlebotomist collects a small blood sample (serum).
• Step 3 — Processing: serum is separated and tested using high-sensitivity immunoassay methods.
• Step 4 — Analysis: labs measure antibody levels targeting the AChR binding site.
• Step 5 — Results: securely delivered within 5–7 business days.

This test is a cornerstone in diagnosing autoimmune myasthenia gravis.

Sample Type

• We take: Venous blood sample (serum)
• Volume: 2–3 mL of serum (typically one red-top or serum separator tube)
• Container: clotting tube (SST) — no anticoagulant
• How it’s collected: standard venipuncture by certified phlebotomist
• Storage: serum must be separated within 2 hours and kept refrigerated (2–8°C) or frozen if delayed
• Note: hemolyzed or lipemic samples may affect accuracy and require recollection

Risks & Safety

• Minimal risk — standard blood draw with slight pain or bruising at the site.
• No fasting or special prep required for this test.
• Safe for adults and older children — no contraindications.
• No side effects from the test itself.

Result Interpretation

Normal Range

• Negative: < 0.02 nmol/L (lab-dependent)
• Levels below cutoff indicate no detectable AChR binding antibodies

Positive Result

• Interpretation: Elevated levels confirm autoimmune myasthenia gravis
  • Mild elevation: early or mild disease
  • Moderate to high: correlates with disease severity in many cases
• Note: ~80–90% of patients with generalized MG test positive; ~50% with ocular MG

Negative Result

• Does not rule out MG — consider testing for muscle-specific kinase (MuSK) or LRP4 antibodies.
• May indicate seronegative myasthenia gravis.
• Clinical evaluation and electrodiagnostic tests (e.g., repetitive nerve stimulation) remain essential.

Consequences if Untreated

• Progressive muscle weakness affecting swallowing, speech, and mobility.
• Myasthenic crisis — life-threatening respiratory failure requiring ICU care.
• Chronic fatigue and disability impacting quality of life.
• Increased risk of pneumonia due to impaired cough reflex.
• Thymoma progression if associated tumor is undiagnosed.

Factors Affecting Test Results

• Immunosuppressive therapy: steroids, azathioprine, or IVIG may lower antibody levels.
• Plasmapheresis or plasma exchange: temporarily reduces antibody concentration.
• Timing of sample: early disease may yield false-negative results.
• Test sensitivity: some labs may miss low-titer cases — use of reference labs recommended.
• Other autoimmune conditions: rare false positives in lupus or autoimmune hepatitis.

FAQs

Limitations

• Negative result does not rule out MG — up to 20% of generalized and 50% of ocular MG cases are seronegative.
• Requires correlation with clinical symptoms, EMG, and imaging (chest CT for thymoma).
• Not useful for monitoring disease activity in all patients — antibody levels don’t always correlate with symptoms.
• Specialized test — must be performed in experienced reference laboratories.
• Turnaround time is longer than routine blood tests (5–7 days).

Book Your AChR Antibody Test Today

Suspect myasthenia gravis? Get a definitive answer with accurate antibody testing.

• Home Blood Collection Available in Dubai, Abu Dhabi, Sharjah & All Emirates
• Precise, Reliable Results in 5–7 Days
• Price: AED 500
• ✅ Accredited Labs | Specialized Neuroimmunology Testing
• 🩸 Certified Phlebotomists | Comfortable at-Home Service
• 🔒 Confidential Reporting | PDF Results Online